These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 10726612)
1. Development, characterization and distribution of adoptively transferred peripheral blood lymphocytes primed by human papillomavirus 18 E7--pulsed autologous dendritic cells in a patient with metastatic adenocarcinoma of the uterine cervix. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Cowan C; Korourian S; Pecorelli S; Cannon MJ; Parham GP Eur J Gynaecol Oncol; 2000; 21(1):17-23. PubMed ID: 10726612 [TBL] [Abstract][Full Text] [Related]
2. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer. Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287 [TBL] [Abstract][Full Text] [Related]
3. Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix. Santin AD; Bellone S; Palmieri M; Bossini B; Roman JJ; Cannon MJ; Bignotti E; Canè S; Pecorelli S Gynecol Oncol; 2003 May; 89(2):271-80. PubMed ID: 12713991 [TBL] [Abstract][Full Text] [Related]
4. Development and therapeutic effect of adoptively transferred T cells primed by tumor lysate-pulsed autologous dendritic cells in a patient with metastatic endometrial cancer. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Cowan C; Coke C; Pecorelli S; Cannon MJ; Parham GP Gynecol Obstet Invest; 2000; 49(3):194-203. PubMed ID: 10729762 [TBL] [Abstract][Full Text] [Related]
5. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Jayaprabhu S; Pecorelli S; Parham GP; Cannon MJ Clin Cancer Res; 2001 Mar; 7(3 Suppl):804s-810s. PubMed ID: 11300476 [TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7. Nonn M; Schinz M; Zumbach K; Pawlita M; Schneider A; Dürst M; Kaufmann AM J Cancer Res Clin Oncol; 2003 Sep; 129(9):511-20. PubMed ID: 12905010 [TBL] [Abstract][Full Text] [Related]
7. Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells. Santin AD; Bellone S; Ravaggi A; Pecorelli S; Cannon MJ; Parham GP Obstet Gynecol; 2000 Sep; 96(3):422-30. PubMed ID: 10960637 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Roman JJ; Parham GP; Cannon MJ J Virol; 2000 May; 74(10):4729-37. PubMed ID: 10775611 [TBL] [Abstract][Full Text] [Related]
9. In vitro induction of tumor-specific HLA class I-restricted CD8+ cytotoxic T lymphocytes from patients with locally advanced breast cancer by tumor antigen-pulsed autologous dendritic cells. Kass R; Agha J; Bellone S; Palmieri M; Canè S; Bignotti E; Henry-Tillman R; Hutchins L; Cannon MJ; Klimberg S; Santin AD J Surg Res; 2003 Jun; 112(2):189-97. PubMed ID: 12888337 [TBL] [Abstract][Full Text] [Related]
10. Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical cancer. Schoell WM; Mirhashemi R; Liu B; Janicek MF; Podack ER; Penalver MA; Averette HE Gynecol Oncol; 1999 Sep; 74(3):448-55. PubMed ID: 10479508 [TBL] [Abstract][Full Text] [Related]
11. Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer. Santin AD; Bellone S; Gokden M; Cannon MJ; Parham GP N Engl J Med; 2002 May; 346(22):1752-3. PubMed ID: 12037163 [No Abstract] [Full Text] [Related]
12. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts. de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722 [TBL] [Abstract][Full Text] [Related]
13. Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells. Kass R; Bellone S; Palmieri M; Canè S; Bignotti E; Henry-Tillman R; Hutchins L; Cannon MJ; Klimberg S; Santin AD Breast Cancer Res Treat; 2003 Aug; 80(3):275-85. PubMed ID: 14503800 [TBL] [Abstract][Full Text] [Related]
14. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer. Santin AD; Bellone S; Palmieri M; Bossini B; Cane' S; Bignotti E; Roman JJ; Cannon MJ; Pecorelli S Int J Gynecol Cancer; 2004; 14(1):64-75. PubMed ID: 14764031 [TBL] [Abstract][Full Text] [Related]
15. Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer. Santin AD; Bellone S; Ravaggi A; Roman JJ; Pecorelli S; Parham GP; Cannon MJ Br J Cancer; 2002 Jan; 86(1):151-7. PubMed ID: 11857027 [TBL] [Abstract][Full Text] [Related]
16. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180 [TBL] [Abstract][Full Text] [Related]
17. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018 [TBL] [Abstract][Full Text] [Related]
18. Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope. Alexander M; Salgaller ML; Celis E; Sette A; Barnes WA; Rosenberg SA; Steller MA Am J Obstet Gynecol; 1996 Dec; 175(6):1586-93. PubMed ID: 8987945 [TBL] [Abstract][Full Text] [Related]
19. Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide. Jochmus I; Osen W; Altmann A; Buck G; Hofmann B; Schneider A; Gissmann L; Rammensee HG J Gen Virol; 1997 Jul; 78 ( Pt 7)():1689-95. PubMed ID: 9225046 [TBL] [Abstract][Full Text] [Related]
20. Identification of novel immunogenic human leukocyte antigen-A 2402-binding epitopes of human papillomavirus type 16 E7 for immunotherapy against human cervical cancer. Jang S; Kim YT; Chung HW; Lee KR; Lim JB; Lee K Cancer; 2012 Apr; 118(8):2173-83. PubMed ID: 21918960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]